510(K) CLEARANCES 49 ▼18RECALLS POSTED 23 ▼3CLASS I 1 ▼1PMA DECISIONS 37 ▼3WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K895210Substantially Equivalent

Labeling Submittal, Adx Amphetamine/methampheta.ii

Abbott Medical, Abbott Park IL / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K895210 is the FDA 510(k) clearance record for LABELING SUBMITTAL, ADX AMPHETAMINE/METHAMPHETA.II, a class II device, cleared for Abbott Laboratories on under FDA product code DKZ (Enzyme Immunoassay, Amphetamine). FDA records list 1,478 510(k) clearances for Abbott Medical, from to . As of , FDA records show no recalls naming K895210.

Clearance record

Decision date
Received
(38 days to decision)
Product code
DKZ Enzyme Immunoassay, Amphetamine
Regulation
21 CFR 862.3100
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Abbott Laboratories One Abbott Park Rd., Abbott Park IL
Third party review
No

Clearances, product code DKZ

Trailing 12 months

FDA records hold no clearances under product code DKZ in the trailing twelve months.

FDA records show no clearances under product code DKZ in the twelve months to November 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DKZ, trailing twelve months
MonthClearances
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260
November 20260